Company news
Vista Pharmaceuticals Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Closure of Trading Window
June 26, 2025
Vista Pharmaceuticals Ltd. Press Release May 30 2025
May 30, 2025
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 30, 2025
Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
May 30, 2025
Vista Pharmaceuticals Ltd. Press Release May 20 2025
May 20, 2025
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2025
May 20, 2025
Vista Pharmaceuticals Ltd. Press Release Apr 30 2025
April 30, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
April 30, 2025
Vista Pharmaceuticals Ltd. Press Release Apr 28 2025
April 28, 2025
General Announcement - Financials Results
April 28, 2025
Vista Pharmaceuticals Ltd. Press Release Apr 23 2025
April 23, 2025
Compliances-Reg.24(A)-Annual Secretarial Compliance
April 23, 2025
Vista Pharmaceuticals Ltd. Press Release Apr 21 2025
April 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
April 21, 2025
Vista Pharmaceuticals Ltd. Press Release Mar 25 2025
March 25, 2025
Closure of Trading Window
March 25, 2025
Vista Pharmaceuticals Ltd. Press Release Mar 20 2025
March 20, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
March 20, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGM
March 20, 2025
Vista Pharmaceuticals Ltd. Press Release Feb 25 2025
February 25, 2025
Notice Of Extra- Ordinary General Meeting Of The Company To Be Held On 20.03.2025
February 25, 2025
Vista Pharmaceuticals Ltd. Press Release Feb 19 2025
February 19, 2025
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
February 19, 2025
Vista Pharmaceuticals Ltd. Press Release Feb 14 2025
February 14, 2025
Closure of Trading Window
February 14, 2025
Board Meeting Intimation for Raising Of Funds By Way Of Issue Of Equity Or Convertible Warrants On Preferential Basis,
February 14, 2025
Vista Pharmaceuticals Ltd. Press Release Feb 12 2025
February 12, 2025
Integrated Filing (Financial)
February 12, 2025
Results For The Quarter And Nine Months Ended 31.12.2024
February 12, 2025
Vista Pharmaceuticals Ltd. Press Release Feb 03 2025
February 3, 2025
Board Meeting Intimation for Un Audited Financials Results For The Quarter Ended 31.12.2024
February 3, 2025
Vista Pharmaceuticals Ltd. Press Release Jan 20 2025
January 20, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
January 20, 2025
Vista Pharmaceuticals Ltd. Press Release Dec 29 2024
December 29, 2024
Closure of Trading Window
December 29, 2024
Vista Pharmaceuticals Ltd. Press Release Nov 14 2024
November 14, 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations AndDisclosure Requirements) Regulations, 2015 - ''Issue Of World Health Organisation (WHO) G.M.P. Certificate.
November 14, 2024
Vista Pharmaceuticals Ltd. Press Release Nov 13 2024
November 13, 2024
Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
November 13, 2024
Vista Pharmaceuticals Ltd. Press Release Nov 07 2024
November 7, 2024
Board Meeting Intimation for For Approval Of Unaudited Financial Results For The Quarter Ended 30.09.2024
November 7, 2024